About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
![](https://ml.globenewswire.com/media/ZmU3ZDg5OWQtMWI2Ni00MWNmLTlkY2ItY2IxNDNiMTYxNzlkLTEyMTE2MTk=/tiny/Acutus-Medical-Inc-.png)
2023 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0376 USD | +25.33% |
|
+25.33% | -81.38% |
May. 13 | Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from S&P TMI Index | CI |
May. 09 | Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M | MT |
About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-81.38% | 1.12M | |
+13.33% | 129B | |
+1.99% | 12.46B | |
-19.52% | 7.02B | |
+52.33% | 6.61B | |
-31.73% | 4.13B | |
+8.95% | 3.46B | |
-17.83% | 2.52B | |
-18.35% | 1.92B | |
-26.90% | 1.62B |